HomeSENORES • NSE
add
Senores Pharmaceuticals Ltd
Previous close
₹791.10
Day range
₹785.60 - ₹820.00
Year range
₹440.30 - ₹876.50
Market cap
36.58B INR
Avg Volume
315.47K
P/E ratio
35.25
Dividend yield
-
Primary exchange
NSE
In the news
Financials
Income Statement
Revenue
Net income
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 1.65B | 60.03% |
Operating expense | 517.00M | 26.59% |
Net income | 316.60M | 84.28% |
Net profit margin | 19.20 | 15.11% |
Earnings per share | 7.29 | — |
EBITDA | 499.80M | 116.63% |
Effective tax rate | 24.71% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.03B | — |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 8.34B | — |
Shares outstanding | 43.43M | — |
Price to book | 4.81 | — |
Return on assets | — | — |
Return on capital | 10.72% | — |
Cash Flow
Net change in cash
| (INR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 316.60M | 84.28% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2017
Website
Employees
194
